Kyntra Bio, Inc. - Common Stock (NQ:KYNB)Price and VolumeDetailed Quote
Top NewsMore NewsPerformance
52-Week Range
80.2% below 52-week high
1.920
2.0052W Low
9.7052W High
1 Week
51.9% below 1-week high
2.001W Low
3.991W High
Kyntra Bio, Inc. - Common Stock (KYNB) traded between $2.00 and $9.70 over the past 52 weeks and last traded at $1.92, 80.2% below its 52-week high. Over the past week it ranged between $2.00 and $3.99.
Past 12 Months
1W
-$1.76
1M
-$3.36
3M
-$5.09
6M
-$4.88
YTD
-$7.58
1Y
-$7.58
KYNB was -79.8% over the past year, -71.8% over six months, -79.8% year to date, -47.8% in the last week.
12 Months vs Market
KYNB
DIA
SPY
QQQ
IWM
Over the past 12 months KYNB returned -79.8% versus DIA (Dow) +7.6%, SPY (S&P 500) +9.6%, QQQ (Nasdaq 100) +8.7% and IWM (Russell 2000) +16.1%.
Volume & Liquidity
1.32× 3-mo avg
Today 37,619
3-mo avg 28.5K
1W
1M
3M
6M
YTD
1Y
KYNB most recently traded 37,619 shares against a 3-month average daily volume of 28.5K. More NewsRead More
Kyntra Bio Q2 2026 Earnings Call: Complete Transcript ↗
August 13, 2026
Kyntra Bio (KYNB) Q1 2026 Earnings Transcript ↗
May 11, 2026
Kyntra Bio (KYNB) Q4 2025 Earnings Call Transcript ↗
March 16, 2026
Frequently Asked QuestionsIs Kyntra Bio, Inc. - Common Stock publicly traded?
Yes, Kyntra Bio, Inc. - Common Stock is publicly traded.
What exchange does Kyntra Bio, Inc. - Common Stock trade on?
Kyntra Bio, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Kyntra Bio, Inc. - Common Stock?
The ticker symbol for Kyntra Bio, Inc. - Common Stock is KYNB on the Nasdaq Stock Market
What is the current price of Kyntra Bio, Inc. - Common Stock?
The current price of Kyntra Bio, Inc. - Common Stock is 1.920
When was Kyntra Bio, Inc. - Common Stock last traded?
The last trade of Kyntra Bio, Inc. - Common Stock was at 11/18/26 11:30 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|
| ||||||||||||||||||||||||